Entry | Author | Date | Location | |
---|---|---|---|---|
Heron Gains FDA Support For Nausea Drug After A Year Under Review | David Holley | 08/10/16 | San Francisco | |
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More | Ben Fidler | 09/04/15 | Boston | |
Tesaro Climbs on Phase 3 Data for Nausea Drug | Ben Fidler | 05/12/14 | Boston | |
Investors Sink Tesaro Shares on Phase 3 Misses For Cancer Drug | Ben Fidler | 12/23/13 | Boston | |
Page 1 of 1 | ||||